These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 14686306)
61. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa. Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R; Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046 [TBL] [Abstract][Full Text] [Related]
62. Benefits and limitations of testing for resistance to HIV drugs. Richman DD J Antimicrob Chemother; 2004 Apr; 53(4):555-7. PubMed ID: 15014064 [TBL] [Abstract][Full Text] [Related]
63. Managing antiretroviral therapy: changing regimens, resistance testing, and the risks from structured treatment interruptions. Eron JJ J Infect Dis; 2008 May; 197 Suppl 3():S261-71. PubMed ID: 18447612 [TBL] [Abstract][Full Text] [Related]
64. Genotypic resistance tests for the management of the patient failing highly active antiretroviral therapy: the resistance pattern in different biological compartments. Liuzzi G Scand J Infect Dis Suppl; 2003; 106():90-3. PubMed ID: 15000595 [TBL] [Abstract][Full Text] [Related]
65. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887 [TBL] [Abstract][Full Text] [Related]
66. HIV drug resistance testing: data be damned. Res Initiat Treat Action; 2000 Dec; 6(4):25-7. PubMed ID: 11708172 [No Abstract] [Full Text] [Related]
71. Retroviruses conference reassuring on new treatments, viral targets, research. AIDS Treat News; 2002 Mar; (378):2-3. PubMed ID: 11965916 [No Abstract] [Full Text] [Related]
72. New global initiatives to improve the interpretation of drug resistance testing for HIV-1. Bean P Am Clin Lab; 2002; 21(7):22-4. PubMed ID: 12380026 [No Abstract] [Full Text] [Related]
73. The 2002 HIV drug guide. Posit Aware; 2002; 13(1):30-53. PubMed ID: 12216528 [No Abstract] [Full Text] [Related]
74. It's time for new leadership at the AACTG. GMHC Treat Issues; 2001 May; 15(5):12. PubMed ID: 11548301 [No Abstract] [Full Text] [Related]
75. 'Test and treat' policies may cause drug resistance, warn researchers. AIDS Policy Law; 2013 May; 28(6):1, 4. PubMed ID: 23828991 [No Abstract] [Full Text] [Related]
76. New targets bring new challenges. Huff B GMHC Treat Issues; 2002 Mar; 16(3):4-6. PubMed ID: 12004798 [No Abstract] [Full Text] [Related]
77. Case files from Stanford University Medical Center: Drug resistance testing in previously untreated patients with HIV--knowing what to look for and choosing appropriate therapy. Shafer RW; Nguyen DP; Fessel WJ MedGenMed; 2006 Aug; 8(3):32. PubMed ID: 17406166 [No Abstract] [Full Text] [Related]
78. [Guidelines on HIV/AIDS]. Afani S A; Pérez C C; Vásquez T P; Wolff R M Rev Chilena Infectol; 2010 Jun; 27(3):197-8. PubMed ID: 20737118 [No Abstract] [Full Text] [Related]
79. New version! Dr. Zachary's practical guidelines on the web. HIV Clin; 2004; 16(1):1. PubMed ID: 15052986 [No Abstract] [Full Text] [Related]